P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)
van Puijenbroek, R., Bosquée, L., Tits, G., Germonpre, P., Strobbe, E., Vansteenkiste, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81080-3
Date:
July, 2005
File:
PDF, 294 KB
english, 2005